November 15, 2026·43 min read

Joby Aviation, Inc. (JOBY), Financial Analysis

Insights derived from analysing SEC filings. Independent analysis, not a publication of the SEC. Figures in $m unless stated.

Revenue Q3 2026
$55.1m
+144.0% year on year (Q3 2025 $22.6m)
Total operating expenses Q3 2026
$333.2m
+63.1% year on year (Q3 2025 $204.2m)
Operating margin Q3 2026
(504.8%)
+299.9 pts year on year (Q3 2025 (804.8%)); operating loss $278.1m
Key findings
  • Q3 2026 revenue $55.1m, +144.0% year on year, of which $53.2m passenger revenue from Blade, bought on 29 Aug 2025, and $1.9m other revenue ($8.9m a year earlier, lower DOD flight services). Gross margin 29.2%. Operating loss $278.1m on costs of $333.2m (+63.1%); net loss $211.8m after a $49.8m fair value gain.
  • FY2026 revenue outlook raised a second time, to $135m to $140m from $115m to $125m (Aug 2026) and $105m to $115m (Feb 2026); 9M 2026 revenue $118.0m. Adjusted EBITDA loss $207.9m in Q3 2026 against $132.8m a year earlier.
  • FAA type certification: stages 1 to 3 complete; the 10-Q puts stage 4 at more than 80% complete. The Q3 2026 letter's chart shows stage 4 at 83% (Joby) and 78% (FAA) and stage 5 at 25% and 14% on 30 Oct 2026, against 12% and 4% for stage 5 on 20 Feb 2026 (chart values, which the letters say may fluctuate). TIA flight testing is expected in H1 2027; 17 aircraft are in production. First eIPP flights in Texas (Sep 2026) and Florida (Oct 2026).
  • Dubai, Toyota and defense: the Nov 2026 letter says Joby continues “to plan for the beginning of operational flight testing there later this year, with a pilot on board”; the Feb 2026 letter announced the first four Dubai vertiports “as we prepare to carry our first passengers later this year”. Toyota reported 13.1% in its 13D/A of 30 Jun 2026 (about 12.6% of shares at 2 Nov 2026, derived) and formed a manufacturing joint venture (Toyota 51%); its second $250m tranche is pending. Resonant Sciences is to be bought for $500m, about $450m in cash, with closing expected in early 2027.
  • Cash and short term investments $2.20bn at 30 Sep 2026; debt carrying value $702.6m after $690.0m of 0.75% convertible notes in Feb 2026. Q3 2026 use of cash $195m against H2 2026 guidance of $385m to $415m; $620.0m remains under the at the market program. A jury awarded Aerosonic $116.9m on 2 Oct 2026; Joby judged a loss not probable and recorded no liability at 30 Sep 2026.
  • Shares closed at $5.08 on 13 Nov 2026, 68.8% below the 52 week closing high, for a market value of $5.17bn and EV/sales of 24.7x TTM revenue. Model prices in three years on the report's own assumptions (EV/sales of FY2029 revenue): $0.93 (worst), $3.44 (base), $8.05 (best).

Figures are read from the Forms 10-K for FY2022 to FY2025, the Forms 10-Q for Q1 2025 to Q3 2026 (Q3 2026 10-Q filed 5 Nov 2026), the Forms 8-K with all their exhibits, incl. the quarterly shareholder letters (Ex 99.2) and results releases (Ex 99.1) with their financial sections, the Resonant Sciences, Toyota joint venture, Ohio property and financing agreements as summarized in Items 1.01 and 2.01, the 2026 proxy statement, the Item 5.07 vote results of 4 Jun 2026, Schedules 13D and 13G and the Forms 4 for central index key 1819848, together with the Forms 10-Q and 8-K of Archer Aviation, BETA Technologies, Eve Holding, Wheels Up, Surf Air Mobility, Kratos and AeroVironment and the Forms 6-K of Vertical Aerospace and EHang used in chapters 2 to 4 and 7. Joby files no separate CFO commentary document, so CFO figures come from the financial summary of the shareholder letters; earnings call remarks are left out. Accession numbers appear in the Sources appendix.

1 Revenue & Business Model

  • Storyline: Joby earns its revenue today from Blade helicopter and jet passenger flights while its electric air taxi moves through the last FAA certification stage; it prepares launch markets in the US through eIPP and in Dubai, scales production with Toyota and adds a defense business through Resonant Sciences, funded from $2.2bn of cash and short term investments. Chapters 2 to 4 cover the drivers: air taxi certification and launch; Blade passenger flights; defense and autonomy.
  • Business (FY2025 10-K): Joby develops a piloted, all electric eVTOL air taxi for a pilot and up to four passengers, at up to 200 mph and a target range of up to 100 miles. Three routes to market: Joby owned and operated service, affiliate service, and direct sales and defense.
  • Revenue to date: $53.4m in FY2025 and $118.0m in 9M 2026, mostly Blade passenger revenue ($111.2m in 9M 2026); other revenue covers government flight services, engineering services and rental income. No aircraft revenue.
  • Reporting: one operating and reportable segment (Services: air transportation and related services); the CEO is the chief operating decision maker. Revenue by type and by region is disclosed: in 9M 2026, US $78.8m, Europe $34.8m and other non US $4.3m.
  • Base: 2,559 employees at 31 Jan 2026; headquarters Santa Cruz, California; production in Marina, California and Dayton and Vandalia, Ohio; over 330 issued or allowed patents (10-K). Auditor PwC from FY2026, after Deloitte and Touche (8-K Item 4.01).
Figure 1.1 Revenue ($m) and operating margin, FY2025 and TTM Q3 2026; quarters in Table 1.1
Figure 1.2 Revenue by region, share of total (%), FY2025 and 9M 2026
Table 1.1 Quarterly income statement, cash flow and cash in $m, Q1 2025 to Q3 2026
Line ($m unless stated)Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Revenue0.00.022.630.824.238.655.1
of which passenger (Blade)0.00.013.721.221.836.253.2
of which other (government flight services, engineering, rental)0.00.08.99.72.52.51.9
Cost of revenue0.00.010.119.318.828.339.0
Research and development134.3136.4149.2161.3177.5194.7208.6
Selling, general and administrative29.031.545.057.161.676.685.6
Total operating expenses (costs)163.3167.9204.2237.6257.8299.5333.2
Operating loss(163.3)(167.9)(181.7)(206.8)(233.6)(260.9)(278.1)
Interest and other income, net9.99.89.713.717.818.916.7
Fair value change of warrants, earn out shares and contingent consideration71.0(126.3)(229.1)72.6106.0(3.3)49.8
Net loss(82.4)(324.7)(401.2)(121.5)(110.0)(245.4)(211.8)
Diluted EPS ($)(0.11)(0.41)(0.48)(0.14)(0.12)(0.25)(0.22)
Adjusted EBITDA (company non GAAP)(127.1)(131.6)(132.8)(154.1)(178.5)(197.0)(207.9)
Stock based compensation27.026.632.941.444.052.054.7
Operating cash flow(111.0)(106.6)(139.2)(153.2)(144.4)(173.1)(168.6)
Capital expenditure(15.0)(12.1)(13.0)(13.8)(77.9)(28.6)(24.7)
Free cash flow(125.9)(118.7)(152.2)(167.0)(222.4)(201.8)(193.4)
Cash, equivalents and short term investments, quarter end812.5991.0978.11.41bn2.47bn2.26bn2.20bn
Weighted average shares (m)766.9796.8844.6894.6943.5969.9978.5
Q4 2025 equals FY2025 less 9M 2025. Cash flow quarters derived from year to date figures. Adjusted EBITDA is a company non GAAP measure from the shareholder letters; Q1 2025 and Q1 2026 equal H1 less Q2.
Table 1.2 Operating metrics and milestones as filed
MetricValues by period
FAA type certification, stage 4 (Joby / FAA)20 Feb 2026: 80% / 73%; 31 Jul 2026: 83% / 77%; 30 Oct 2026: 83% / 78%
FAA type certification, stage 5 (Joby / FAA)20 Feb 2026: 12% / 4%; 31 Jul 2026: 20% / 10%; 30 Oct 2026: 25% / 14%
AircraftQ2 2026: five flying, 12 in production; Q3 2026: 17 in production, work orders for the 18th
Blade passengersQ3 2025: about 40,000; Q3 2026: over 44,000
USAF autonomy contractstotal commitment from about $20m to nearly $37m (Oct 2026); operational testing ceiling from $5m to $50m
FAA certificatesPart 135 air carrier (2022), Part 145 repair station (Feb 2024), Part 141 flight school (Dec 2024)
Employees2,559 at 31 Jan 2026
Stage percentages are the bar chart values in the shareholder letters (8-K Ex 99.2, data dates 20 Feb, 31 Jul and 30 Oct 2026), read from the filed chart images; the letters state that percentage completion may fluctuate mildly as documents are edited and resubmitted. The Q3 2026 10-Q text states only that Joby has completed or substantially completed three of five stages and is more than 80% complete in the fourth.

2 Air Taxi: FAA Stage 5, eIPP Flights, Dubai and the Toyota Production Ramp

  • Certification (Q3 2026 letter): stages 1 to 3 of Joby's five stage path are complete; on 30 Oct 2026 stage 4 (testing and analysis) stood at 83% on Joby's count and 78% on the FAA's, and stage 5 (show and verify) at 25% and 14%. For credit tests in Q3 2026 covered the fuselage, propeller hubs, tail, ruddervators, tilt actuators and recorder. TIA flight testing is expected in H1 2027; the FAA indicated that carrying passengers under eIPP requires substantial TIA testing.
  • US launch through eIPP: flights began in the Dallas Fort Worth area in Sep 2026 and continued in Tampa and Orlando in Oct 2026; Joby leased a 45,000 square foot base at Perot Field. The 10-Q states a target of first passengers in 2026.
  • Dubai: the 2024 RTA agreement gives a six year exclusive right to operate air taxis in Dubai (10-K). The Feb 2026 letter announced the first four Dubai vertiports “as we prepare to carry our first passengers later this year”; the Nov 2026 letter reports the second vertiport complete and says Joby continues “to plan for the beginning of operational flight testing there later this year, with a pilot on board”.
  • Production with Toyota: 17 aircraft in production and work orders for the 18th; output across eight core shops rose 37% from Q1 to Q3 2026 and articles with a nonconformance fell 38%. A Toyota veteran now runs the Marina site; JTAMPC (Toyota 51%) is to manufacture the S4 Series; the Vandalia, Ohio plant (728,000 square feet, $61.5m) supports a target of four aircraft a month in 2027.

How the air taxi industry is changing

  • eIPP (Joby Q1 2026 release; Archer and BETA Forms 8-K): Joby was named in applications covering up to 11 states; Archer in 3 winning applications covering 8 states; BETA launched 6 of 7 eIPP selections.
  • Certification stages differ by company: Archer reports phase 4 of 4 of its FAA process and a Market Survey Special Airworthiness Certificate (8-K of 9 Nov 2026); BETA's A250 holds the same certificate type (8-K of 3 Nov 2026).
  • Eve and Vertical: Eve plans the first flight of its first conforming prototype in H2 2027; Vertical flew piloted transition with two Valo prototypes in 2026 (8-K of 5 Nov 2026; 6-K of 13 Aug 2026).
  • Middle East: Joby's Q1 2026 10-Q names military actions in the Middle East as a risk to Dubai operations.
Figure 2.1 FAA stage 4 and 5 completion
Figure 2.2 Quarterly revenue of eVTOL companies
Figure 2.3 Cash and short term investments of eVTOL companies
Table 2.1 eVTOL companies compared ($m unless stated)
CompanyPeriodFiled detailRevenueGrowth (%)Operating loss
Joby AviationQ3 2026mostly Blade passenger revenue; stage 5 at 25% (Joby) and 14% (FAA) in the letter chart; 17 aircraft in production55.1+144.0%(278.1)
Archer AviationQ3 2026Hawthorne Airport services and leases; phase 4 of 4 of its FAA process5.1n/a(289.2)
BETA TechnologiesQ3 2026products $5.2m, services $12.5m; A250 Market Survey Special Airworthiness Certificate17.7+98.0%(127.8)
Eve HoldingQ3 2026no revenue; first conforming prototype flight planned H2 2027niln/a(54.3)
Vertical AerospaceH1 2026piloted transition with two Valo prototypes in 2026; H1 income statement not extractedniln/an/a
EHangQ2 202636 eVTOL delivered; FY2026 RMB600m revenue guidance withdrawn11.5(31.3%)(19.4)
Latest filed period as labelled; growth year on year. Archer, BETA and Eve from their Forms 10-Q and 8-K for Q3 2026; Vertical from its H1 2026 6-K; EHang from its Q2 2026 6-K, converted from RMB as filed. Certification stages are each company's own description.

3 Blade Passenger Flights: The Revenue Base Today

  • Passenger revenue $53.2m in Q3 2026 against $13.7m in Q3 2025, when Blade was owned for about one month; 9M 2026 passenger revenue $111.2m of $118.0m total. Blade flew over 44,000 passengers in Q3 2026, the most in any quarter of its history (letter).
  • Drivers as filed: New York airport passengers +61% year on year and new airport passengers more than doubled (Q3 2026); seats sold +50% and Hamptons revenue +40% in Q2 2026; service to Circuit of the Americas, Austin; BLADEone jet service between New York, Miami and Palm Beach.
  • Deal terms: $92.4m initial consideration incl. 5,325,585 shares; the EBITDA earn out reached its $17.5m maximum and was paid in 2,419,801 shares in Sep 2026, after milestones in the first twelve months (10-Q; 8-K of 11 Sep 2026).
  • Margin: gross margin on total revenue was 29.2% in Q3 2026; Blade buys flights from third party operators under capacity purchase agreements at fixed hourly rates (10-Q).

How the air mobility market around Blade is changing

  • Seasonality (10-Q): Blade revenue peaks in Q2 and Q3 with summer travel and is lower in Q1 and Q4.
  • Operators (Forms 10-Q): Wheels Up Q3 2026 revenue $164.8m, (11.2%) year on year, operating loss $50.3m; Surf Air Mobility $36.5m, +25.0%, operating loss $16.0m.
  • Distribution: Blade services are being integrated into the Uber app (10-K); Visa Infinite benefits on the New York airport service and Virgin Atlantic as exclusive UK airline partner (Q2 2026 letter).
Figure 3.1 Revenue by type, quarterly
Figure 3.2 Quarterly revenue of US air mobility operators
Table 3.1 Passenger air mobility operators compared ($m unless stated)
CompanyPeriodFiled detailRevenueGrowth (%)Operating loss
Joby Aviation (passenger revenue)Q3 2026Blade helicopter and jet flights in the US and Europe; over 44,000 passengers53.2+289.8%n/a
Wheels Up ExperienceQ3 2026private aviation memberships and charter164.8(11.2%)(50.3)
Surf Air MobilityQ3 2026scheduled and on demand regional flights36.5+25.0%(16.0)
Joby passenger growth compares a full quarter of Blade with about one month in Q3 2025. Wheels Up and Surf Air from their Q3 2026 Forms 10-Q.

4 Defense and Autonomy: Air Force Contracts and the Resonant Sciences Purchase

  • Contracts: the US Air Force raised its total commitment for Joby's autonomy technology from about $20m to nearly $37m and the ceiling for operational testing from $5m to $50m, after the Superpilot system flew a Cessna Caravan 3,199 miles coast to coast with zero disengagements (Q3 2026 letter; 10-Q).
  • Resonant Sciences (8-K of 11 Aug 2026, pending; company figures also in the Q3 2026 letter): $500m base price, about $450m in cash and $50m in stock at $7.4752; Resonant designs RF and mission systems, radomes and low observability structures, with about 250 employees, revenue over $100m in the TTM to Jul 2026 (about 40% growth) and high teens adjusted EBITDA margins (company statements). Closing is expected in early 2027.
  • Structure: Resonant is to become Joby's defense business, absorbing the turbine electric, hydrogen electric and autonomy programs, while the commercial unit focuses on the air taxi (Q3 2026 letter).
  • Revenue today: other revenue, incl. government flight services, was $1.9m in Q3 2026 against $8.9m a year earlier (10-Q).

How defense demand for autonomous aircraft is changing

  • Listed suppliers (Forms 10-Q): Kratos revenue $471.8m in Q3 2026, +35.7%; AeroVironment $480.5m in the quarter to 1 Aug 2026, +5.7%.
  • eVTOL peers move into defense: Archer agreed to buy Boeing's Wisk, SkyGrid and Insitu (8-K of 10 Aug 2026, pending); BETA reports services revenue of $12.5m incl. government work in Q3 2026.
  • Joby and L3Harris: a turbine electric autonomous VTOL flew three months after its announcement (Q4 2025 letter) and completed a 148 mile flight at maximum take off weight (Q1 2026 release).
Figure 4.1 Defense revenue scale
Table 4.1 Defense activity compared as filed
CompanyPeriodFiled detailValue ($m)
Joby AviationOct 2026USAF autonomy contracts, total commitment nearly $37m; L3Harris turbine electric aircraftabout 37
Joby AviationpendingResonant Sciences, revenue over $100m TTM to Jul 2026 (company statement in Forms 8-K)over 100
Kratos Defense & Security SolutionsQ3 2026revenue +35.7% year on year; operating loss $4.9m471.8
AeroVironmentquarter to 1 Aug 2026revenue +5.7%; operating loss $10.9m480.5
Archer AviationpendingInsitu from Boeing, over $200m a year (company estimate)over 200
BETA TechnologiesQ3 2026services revenue incl. government work12.5
Resonant and Insitu revenue are company statements stated as over the value shown; neither has filed financial statements with the SEC.

5 Financial Analysis & Ratios

  • Operating loss TTM $979.3m on revenue of $148.8m; FY2025 operating loss $719.6m against $596.8m in FY2024. Gross margin 29.2% TTM and 29.2% in Q3 2026.
  • Net loss TTM $688.8m after interest and other income of $67.2m and a fair value gain of $225.0m on warrants, earn out shares and contingent consideration. The public warrants expired on 10 Aug 2026; the earn out share liability was $56.1m and the Delta warrant liability $12.1m at 30 Sep 2026.
  • Free cash flow TTM ($784.5m): operating cash flow ($639.4m) and capital expenditure $145.1m. 9M 2026 operating cash use $486.2m against $356.7m in 9M 2025; capex $131.3m incl. the Ohio building.
  • Balance sheet at 30 Sep 2026: cash $521.5m and short term investments $1.68bn; debt carrying value $702.6m; property and equipment $241.5m; goodwill $89.4m; total equity $1.75bn; accumulated deficit $3.35bn.
  • Adjusted EBITDA (company non GAAP): loss of $456.7m in FY2024, $545.6m in FY2025 and $737.6m TTM; it excludes stock based compensation ($192.1m TTM), depreciation ($46.0m TTM), acquisition costs and fair value changes.
  • Capital returns: no dividends and no buybacks in any year shown.
Table 5.1 Income statement, cash flow and balance sheet summary ($m unless stated)
Line itemFY2021FY2022FY2023FY2024FY2025TTM Q3 2026
Revenue0.00.01.00.153.4148.8
Gross profit0.00.00.80.124.143.4
Research and development197.6296.3367.0477.2581.1742.0
Selling, general and administrative61.595.9105.9119.7162.6280.8
Operating income(259.1)(392.2)(472.1)(596.8)(719.6)(979.3)
Net income(180.3)(258.0)(513.1)(608.0)(929.8)(688.8)
Diluted EPS ($)(0.61)(0.44)(0.79)(0.87)(1.13)(0.73)
Operating cash flow(195.7)(235.9)(313.8)(436.3)(509.9)(639.4)
Capital expenditure(32.3)(54.9)(30.6)(40.6)(53.9)(145.1)
Free cash flow(228.1)(290.8)(344.4)(476.9)(563.8)(784.5)
Stock based compensation26.969.193.6104.4127.9192.1
Cash and investments1,298.81,056.81,032.3932.91,407.92,197.9
Total debt0.00.00.00.00.0702.6
Total equity1,316.81,164.71,034.4912.41,409.71,746.8
Values in $m. Capital expenditure is purchases of property and equipment; free cash flow is operating cash flow less capex. Cost of revenue is part of total operating expenses. TTM equals FY2025 plus 9M 2026 less 9M 2025.
Figure 5.1 Quarterly revenue and margins
Table 5.2 What changed, Q3 2026 against Q3 2025
MetricQ3 2025Q3 2026Change
Revenue ($m)22.655.1144.0%
Gross profit ($m)12.516.128.4%
Operating income ($m)(181.7)(278.1)(53.1%)
Net income ($m)(401.2)(211.8)47.2%
Diluted EPS ($)(0.48)(0.22)54.2%
Operating cash flow ($m)(139.2)(168.6)(21.2%)
Free cash flow ($m)(152.2)(193.4)(27.0%)
Operating margin (%)(804.8)(504.8)299.9 pts
Net margin (%)(1,777.4)(384.5)1,392.9 pts
Table 5.3 Ratio analysis
RatioFY2021FY2022FY2023FY2024FY2025TTM Q3 2026
Liquidity and leverage
Current ratio (x)95.2235.9023.3920.1424.0918.29
Debt to equity (x)0.000.000.000.000.000.40
Net cash ($bn)1.31.11.00.91.41.5
Revenue before FY2025 was below $1.1m a year, so growth, margins on revenue and returns ratios are left out; Table 5.2 gives Q3 2026 margins. Net cash uses cash and short term investments less debt carrying value.
Figure 5.2 Operating cash flow, capital expenditure and free cash flow
Table 5.4 Valuation snapshot at $5.08 per share, close of 13 Nov 2026
MeasureValue
Market cap ($bn)5.2
Enterprise value ($bn)3.7
EV/Sales (TTM) (x)24.7
FCF yield (%)(15.2)
Price/Book (x)3.0

Cost structure and profitability

  • Costs (revenue less operating income) $333.2m in Q3 2026, +63.1% year on year, on revenue of $55.1m; costs were 6.0 times revenue against 9.0 times a year earlier. 9M 2026 total operating expenses $890.5m.
  • Research and development $208.6m (+39.8%) and SG&A $85.6m (+90.1%); stock based compensation $54.7m in Q3 2026 against $32.9m, of which R&D $39.5m and SG&A $15.1m; $192.1m TTM.
  • Cost of revenue $39.0m against revenue of $55.1m; gross profit $16.1m, a margin of 29.2%, against 55.4% in Q3 2025 when other revenue was a larger share.
  • Segment expense detail (10-Q): personnel costs excluding stock based compensation $123.4m in Q3 2026 against $94.8m a year earlier; other segment items $138.6m against $67.0m.
Figure 5.3 Costs by line against revenue, quarterly
Table 5.5 Revenue and cost lines, Q3 2026 against Q3 2025 ($m)
Line ($m unless stated)Q3 2025Q3 2026Change
Passenger revenue13.753.2+289.8%
Other revenue8.91.9(79.1%)
Cost of revenue10.139.0+287.9%
Research and development149.2208.6+39.8%
Selling, general and administrative45.085.6+90.1%
Total operating expenses204.2333.2+63.1%
Adjusted EBITDA (company non GAAP)(132.8)(207.9)+56.6%
Stock based compensation32.954.7+66.3%
Capital expenditure13.024.7+90.0%
Cash, equivalents and short term investments978.12.20bn+124.7%
Lines not in Table 5.2. Changes in losses are shown as the change in size. Q3 2025 includes about one month of Blade.

Funding and cash runway: equity, convertible notes, Toyota and the ATM

  • Cash and short term investments rose from $1.41bn at 31 Dec 2025 to $2.20bn at 30 Sep 2026 after $576.3m of shares at $11.35 and $669.7m net of convertible notes in Feb 2026, $70.0m from Delta's warrant exercise and $128.2m net from the at the market program; Q3 2026 free cash flow ($193.4m).
  • Runway arithmetic (derived): at the H2 2026 guidance midpoint of $400m per half year, $2.2bn would cover about 2.7 years before the $450m cash part of the Resonant price; after it, about 2.2 years. Joby states that cash covers at least twelve months.
  • Toyota: about $650m invested by 31 Dec 2025, incl. the first $250m tranche in May 2025 at $5.03; the second $250m tranche awaits the joint venture's Future Agreements (8-K of 30 Jun 2026).
  • Debt carrying value $702.6m: $690.0m convertible notes due Feb 2032 at 0.75% and a $30.75m mortgage at 6.784% due Mar 2036; interest expense on the notes $5.5m in 9M 2026.
Figure 5.4 Cash and short term investments against free cash flow
Table 5.6 Capital raised since May 2025
DateTypeShares (m)Proceeds ($m)
May 2025Toyota private placement, 49,701,790 shares at $5.03 (first tranche)49.70250.0
Oct 2025Underwritten offering, 35,075,000 shares35.08575.9 net
Jan 2026Delta warrant first tranche, 7,000,000 shares at $107.0070.0
Feb 2026Underwritten offering, 52,863,437 shares at $11.3552.86576.3 net
Feb 20260.75% convertible senior notes due 2032 (conversion price about $14.19)n/a669.7 net of $690.0 principal
Mar 2026Mortgage loan on the Ohio facility, 6.784%, due Mar 2036n/a30.75
Aug to Sep 2026At the market sales under the $750m program20.17128.2 net
Net proceeds where stated as net; capped call cost $63.3m paid from the note proceeds.
Table 5.7 Debt at 30 Sep 2026
InstrumentRate and termsMaturityAmount ($m)
0.75% convertible senior notes due 15 Feb 2032conversion price about $14.19; capped calls to $22.70 (cost $63.3m)Feb 2032690.0 principal; 671.8 carrying
Mortgage loan, Vandalia, Ohiofixed 6.784%, interest onlyMar 203630.75
Debt carrying value, 30 Sep 2026702.6

Guidance track

  • FY2026 revenue outlook: $105m to $115m (25 Feb 2026), $115m to $125m (5 Aug 2026), $135m to $140m (4 Nov 2026). Q4 2026 revenue implied by the new range is $17.0m to $22.0m (derived), below Q3 2026 in line with the seasonal pattern the 10-Q describes.
Figure 5.5 FY2026 revenue outlook by release date

6 MD&A & Management Commentary

Q3 2026 shareholder letter, results release and 10-Q MD&A

  • Q3 2026 (8-K Ex 99.2 of 4 Nov 2026): revenue $55.1m; operating expenses $333.2m incl. stock based compensation $54.7m and depreciation $12.1m; net loss $211.8m, down $189.4m year on year on a $278.9m favorable fair value change; Adjusted EBITDA loss $207.9m, up $75.1m year on year and $10.8m on Q2 2026.
  • Cash (letter): cash and investments of $2.2bn incl. about $128m net at the market proceeds; Q3 2026 use of cash and short term investments $195m. H1 2026 use was $365m excl. the $32m Ohio building, within the $340m to $370m guidance.
  • Costs (10-Q MD&A): R&D $208.6m, +40% year on year, on personnel for engineering, software, prototype manufacturing and certification. SG&A $85.6m, +90%, on a full quarter of Blade, legal and marketing spend, stock based compensation, payroll and Resonant acquisition costs ($3.5m).
  • Liquidity (10-Q): cash, equivalents and short term investments are expected to cover at least the next twelve months; long term funding is expected from cash on hand, the second Toyota tranche and future operations, with equity and debt for any remaining needs. $620.0m remains under the at the market program.
  • Legal (10-Q): Aerosonic jury verdict of $116.9m (2 Oct 2026) in a trade secret case on air data probes; Joby plans post trial motions and appeal; loss judged reasonably possible but not probable, so no liability is recorded; Aerosonic filed a motion for injunctive relief on 2 Nov 2026. Archer: Joby's suit continues after Archer's counterclaims were dismissed with prejudice on 29 Sep 2026; Archer's ITC case covers 4 patents, hearing Jan 2027, final decision scheduled by 14 Sep 2027.
Table 6.1 Outlook as filed, with every 2026 revision
ItemOutlookSource
FY2026 revenue$135m to $140m (raised); 9M 2026 actual $118.0m8-K Ex 99.1 and 99.2, 4 Nov 2026
FY2026 revenue, Aug 2026$115m to $125m (raised)8-K Ex 99.2, 5 Aug 2026
FY2026 revenue, Feb 2026$105m to $115m (first outlook)8-K Ex 99.2, 25 Feb 2026
H2 2026 use of cash and short term investments$385m to $415m (Aug and Nov 2026); Q3 2026 actual $195m8-K Ex 99.2, 5 Aug and 4 Nov 2026
H1 2026 use of cash and short term investments$340m to $370m excl. about $33m Ohio building; actual $365m excl. $32m8-K Ex 99.2, 25 Feb and 5 Aug 2026
First passengersDubai vertiports announced “as we prepare to carry our first passengers later this year” (Feb 2026); targeting first passengers in 2026 (10-Q Q3 2026); Dubai operational flight testing with a pilot on board later in 2026 (Nov 2026)8-K Ex 99.2, 25 Feb and 4 Nov 2026; 10-Q
TIA flight testingFAA pilots expected to fly in 2026 (Feb 2026); FAA pilot training and Joby flight testing of the TIA aircraft expected H1 2027 (Nov 2026)8-K Ex 99.2, 25 Feb and 4 Nov 2026
Productiondouble to four aircraft a month in 20278-K Ex 99.1, 7 Jan 2026; Q4 2025 letter
Resonant Sciences closingfirst half of 2027 (Aug 2026); early 2027 (Nov 2026)8-K Ex 99.1, 11 Aug 2026; Q3 2026 letter

Management and CFO commentary

  • Q3 2026 shareholder letter (4 Nov 2026), CEO JoeBen Bevirt: for credit testing in the final certification stage, eIPP flights in Texas and Florida, Blade's 44,000 passengers, the coast to coast autonomous flight and the Resonant purchase as a dedicated defense business; the CEO plans to fly on the first aircraft designated for passenger testing.
  • Q3 2026 financial summary (no separate CFO document filed): other income $66.5m incl. a $49.8m fair value gain; Q3 2026 use of cash $195m; FY2026 revenue outlook raised to $135m to $140m on Blade; H2 2026 cash use kept at $385m to $415m.
  • Q2 2026 letter (5 Aug 2026): five aircraft flying and 12 in production, two planned for delivery in 2026; on many Blade routes aircraft availability, not demand, limits growth; Atoms partnership for mobility hubs in Florida, New York, Texas and California.
  • Q4 2025 letter (25 Feb 2026): record 18 point progress on the FAA side of stage 4; first four Dubai vertiports announced “as we prepare to carry our first passengers later this year”; plan to double production to four aircraft a month in 2027; more than $1bn of potential aircraft and service sales disclosed in 2025.
Table 6.2 Management statements in their own words
SpeakerDate and sourceStatement
JoeBen Bevirt, founder and CEO4 Nov 2026, Q3 2026 release (Ex 99.1)“This quarter, we made important progress on the fifth and final stage of certification”
JoeBen Bevirt, founder and CEO4 Nov 2026, Q3 2026 letter (Ex 99.2)“We continue to scale manufacturing with the support of our partners at Toyota”
JoeBen Bevirt, founder and CEO25 Feb 2026, Q4 2025 release (Ex 99.1)“2026 will mark a key inflection point for Joby.”
Table 6.3 Key disclosures in the Forms 10-Q and 10-K
ItemDisclosure
10-Q Q3 2026, BladeAcquired 29 Aug 2025 for $92.4m initial consideration incl. 5,325,585 shares ($74.5m); EBITDA earn out reached its maximum and was settled for $17.5m in 2,419,801 shares on 8 Sep 2026; retention earn out liability $12.8m.
10-Q Q3 2026, AtomsCommitment of up to $50.0m to a vertiport joint venture with an affiliate of Atoms; $1.0m contributed, $49.0m unfunded.
10-Q Q3 2026, debtConvertible notes $671.8m carrying ($690.0m principal, $18.2m unamortized costs); mortgage $30.75m at 6.784% due Mar 2036, collateral $60.8m.
10-Q Q3 2026, warrants14,234,861 public warrants expired 10 Aug 2026 (gain $56.4m in 9M 2026); Delta exercised 7,000,000 warrants at $10 on 12 Jan 2026; second tranche of 5,833,333 at $12 remains subject to a milestone.
10-Q Q3 2026, related partyToyota holds over 10%; parts and materials payments $1.7m in 9M 2026; CEO linked vendors $0.5m.
10-K FY2025, certificationRevised stage 4 G‑1 certification basis signed Jul 2022, published in the Federal Register Mar 2024; Part 135, 145 and 141 certificates held.
10-K FY2025, DubaiRTA agreement (2024) gives a six year exclusive right to operate air taxis in Dubai, with RTA support incl. financial mechanisms.
10-K FY2025, partnersToyota invested nearly $650m by 31 Dec 2025; Uber app integration; Delta invested $60m with warrants; Abdul Latif Jameel memorandum for up to 200 aircraft valued at about $1bn in Saudi Arabia.

7 Peer Valuation & Sector Summary

  • Sector: advanced air mobility (eVTOL air taxis) with charter operators and defense suppliers as adjacent markets. eVTOL peers filing with the SEC: Archer Aviation, BETA Technologies and Eve Holding at Q3 2026 (Forms 10-Q), Vertical Aerospace at H1 2026 and EHang at Q2 2026 (Forms 6-K).
  • Revenue TTM: Joby $149m against BETA $54m and Archer $12.0m; Eve and Vertical report no revenue; EHang $11.5m in Q2 2026 alone.
  • Operating loss TTM: Joby $979m, Archer $1.06bn, BETA $554m, Eve $225m. Free cash flow TTM: Joby ($784m), Archer ($730m), BETA ($470m), Eve ($200m).
  • Valuation: market value Joby $5.17bn (13 Nov 2026), Archer $3.80bn, BETA $6.49bn, Eve $0.67bn (11 Nov 2026); EV/sales TTM Joby 24.7x, BETA 99.5x, Archer 211.6x. Figure 7.1 sets market value and free cash flow against each company's cash.
Table 7.1 Peer comparison, latest reported trailing twelve months
CompanyRevenue TTM ($bn)Revenue growth (%)Gross margin (%)Operating margin (%)Net margin (%)Net cash ($bn)Market value ($bn)EV/Sales (x)
JOBY0.1144.029.2n/an/a1.5524.7
ACHR0.0n/a9.2n/an/a1.34211.6
BETA0.198.062.5n/an/a1.2699.5
EVEX0.0n/an/an/an/a0.01n/a
EVTL0.0n/an/an/an/an/an/an/a
EHn/a(31.3)61.2(169.1)(164.7)n/an/an/a
JOBY at the 13 Nov 2026 close; ACHR, BETA and EVEX at 11 Nov 2026 closes, TTM to Q3 2026 from their Forms 10-Q; EVTL from its H1 2026 6-K (cash only); EH Q2 2026 quarter only (6-K of 25 Aug 2026). Growth is Q3 2026 against Q3 2025 (EH Q2). Gross margins are TTM (JOBY 29.2% also in Q3 2026; JOBY uses its filed cost of revenue line). Peer rows are identical to the ACHR post, which priced JOBY at the 11 Nov 2026 close of $5.88. BETA market value uses Q3 2026 weighted shares (234.3m). EVEX equity was negative at 30 Sep 2026. Revenue rounds to 0.0 in $bn; Table 7.2 gives $m.
Figure 7.1 Revenue growth versus operating margin, peer set
Table 7.2 eVTOL peers in $m
CompanyPeriodRevenue ($m)Operating loss ($m)Free cash flow ($m)Cash and short term investments ($m)Market value ($bn)
Joby Aviation (JOBY)TTM Q3 2026149.0(979)(784)2.20bn5.17
Archer Aviation (ACHR)TTM Q3 202612.0(1,057)(730)1.35bn3.80
BETA Technologies (BETA)TTM Q3 202654.0(554)(470)1.34bn6.49
Eve Holding (EVEX)TTM Q3 20260.0(225)(200)3560.67
Vertical Aerospace (EVTL)H1 2026 (cash at 13 Aug 2026)niln/aabout (150) expected next 12 months134n/a
EHang Holdings (EH)Q2 2026 quarter only11.5(19)n/a137n/a
Market values: JOBY at 13 Nov 2026, others at 11 Nov 2026. Eve cash incl. financial investments, debt $322.1m. EHang converted from RMB at the rate in its 6-K.

8 Material Events & Contracts

  • 18 Forms 8-K from 5 Nov 2025 to 4 Nov 2026: five results releases, the Kazakhstan letter of intent, the Ohio facility purchase and mortgage, the Feb 2026 equity and convertible note offerings, an auditor change, the Toyota joint venture, the expiry of the listed warrants, the Resonant Sciences agreement and the $750m at the market program, the Blade earn out shares, two officer changes and the annual meeting.
  • Material contracts: the Resonant Sciences stock purchase agreement, the Toyota stock purchase agreement and JTAMPC stockholders agreement, the indenture for the 2032 convertible notes with capped calls, the Ohio purchase and mortgage loan, the equity distribution agreement and the Dubai RTA agreement.
Table 8.1 18 Forms 8-K filed from 5 Nov 2025 to 4 Nov 2026
DateItemsEvent
5 Nov 20257.01, 9.01Power on testing of the first FAA conforming aircraft for Type Inspection Authorization; entry into the final stage of type certification
5 Nov 20252.02, 9.01Q3 2025 results: cash and investments $978.1m; about 40,000 Blade passengers; Oct 2025 equity offering net about $576m
6 Nov 20257.01, 9.01Letter of intent to sell aircraft and services worth up to $250m to Alatau Advance Air Group, Kazakhstan, incl. pre delivery payments
7 Jan 20261.01, 7.01, 9.01Agreement to buy a 728,000 square feet facility in Vandalia, Ohio for $61.5m ($1.0m deposit); production target four aircraft a month in 2027
2 Feb 20261.01, 2.02, 2.03, 9.0152,863,437 shares at $11.35 and $690.0m 0.75% convertible notes due 2032 (conversion price about $14.19), capped calls at $22.70 costing $63.3m; preliminary cash $1.41bn at 31 Dec 2025
25 Feb 20262.02, 9.01Q4 2025 results: revenue $30.8m, net loss $121.5m, Adjusted EBITDA loss $154.1m; FY2026 revenue outlook $105m to $115m; H1 2026 cash use $340m to $370m
6 Mar 20264.01, 9.01Change of independent auditor; Deloitte and Touche letter (Ex 16.1) agrees with the statements in the first three paragraphs
11 Mar 20261.01, 2.01, 2.03, 9.01Ohio facility purchase closed 6 Mar 2026 for $61.5m; $30.75m ten year interest only mortgage loan (6.784%, due Mar 2036)
22 Apr 20265.02Didier Papadopoulos, President of Aircraft OEM, to resign effective 3 Jul 2026 and stay as adviser
5 May 20262.02, 9.01Q1 2026 results: revenue $24.2m, net loss $110.0m; cash and investments $2.5bn; first FAA conforming aircraft flew; SR3 audit completed
4 Jun 20265.07Annual meeting 2 Jun 2026: three Class II directors elected, PwC ratified, say on pay approved
30 Jun 20261.01, 9.01Joint venture JTAMPC with Toyota (Joby 49%, Toyota 51%) to manufacture the S4 Series; future agreements are a condition of Toyota's second $250m tranche
28 Jul 20268.0114,237,486 public warrants at $11.50 to expire 10 Aug 2026; NYSE to suspend the listed warrants trading after 7 Aug 2026
5 Aug 20262.02, 9.01Q2 2026 results: revenue $38.6m (Blade $36.2m), net loss $245.4m, Adjusted EBITDA loss $197.0m; FY2026 revenue outlook raised to $115m to $125m; H2 cash use $385m to $415m
11 Aug 20261.01, 3.02, 7.01, 8.01, 9.01Agreement to buy Resonant Sciences for $500m base price (about $450m cash, $50m stock at $7.4752); outside date 8 Feb 2027; $750m at the market program
9 Sep 20265.02Controller Sergey Novikov appointed Principal Accounting Officer
11 Sep 20268.01, 9.01Resale prospectus for 2,419,801 shares issued for the Blade EBITDA earn out
4 Nov 20262.02, 9.01Q3 2026 results: revenue $55.1m, net loss $211.8m, Adjusted EBITDA loss $207.9m; FY2026 revenue outlook $135m to $140m; cash and short term investments $2.2bn
Table 8.2 Material contracts and financing arrangements
ContractTerms
Resonant Sciences stock purchase agreement (8 Aug 2026, pending)$500.0m base price, about $50.0m in stock at $7.4752; termination right after 8 Feb 2027, extendable for approvals (Table 8.3).
Toyota stock purchase agreement and JTAMPC stockholders agreementsecond $250m tranche pending; joint venture for S4 Series manufacturing, Toyota 51% (Table 8.4).
Indenture, 0.75% convertible senior notes due 2032 (2 Feb 2026)$690.0m; conversion rate 70.4846 shares per $1,000 (about $14.19); redeemable from 20 Feb 2029 subject to a 130% price test; capped calls to $22.70.
Ohio property purchase and mortgage loan (Mar 2026)728,000 square feet in Vandalia for $61.5m; $30.75m ten year interest only loan.
Equity distribution agreement (11 Aug 2026)up to $750.0m at the market; $128.2m net raised by 30 Sep 2026.
Dubai RTA agreement (2024)six year exclusive right to operate air taxis in Dubai (10-K).
Table 8.3 Resonant Sciences stock purchase agreement, terms as filed (8-K of 11 Aug 2026)
TermDetail
TargetStrix Holdings, Inc., owner of Resonant Sciences, LLC, Dayton, Ohio: RF and mission systems, radomes and low observability technology; about 250 employees
Price$500.0m base, adjusted for closing cash, debt, expenses and working capital; about $450m in cash
Sharesabout $50.0m in common stock to management members at $7.4752 per share (20 day VWAP before signing); resale to be registered
Conditionspre closing restructuring, regulatory and national security approvals, no material adverse effect
Datestermination right if not closed by 8 Feb 2027, extendable for regulatory approvals; Joby expects closing in early 2027
Company figures for the targetrevenue over $100m in the TTM to Jul 2026, about 40% growth; high teens adjusted EBITDA margins; H1 2026 bookings over three times the prior year (company statements in the 8-K Ex 99.1 of 11 Aug 2026 and the Q3 2026 letter; no Resonant financial statements filed)
Table 8.4 Toyota agreements as filed
AgreementDetail
Stock purchase agreement (Oct 2024, amended May 2025)up to $500m in two tranches; first $250m closed May 2025 at $5.03 per share (49,701,790 shares; $40.3m non cash loss)
Second tranche$250m, pending; condition includes the Future Agreements of the joint venture (8-K of 30 Jun 2026)
JTAMPC joint venture (29 Jun 2026)manufactures the S4 Series; Toyota 51% ($1.02m), Joby 49% ($0.98m); board of five, three named by Toyota; exclusive manufacturing supply agreement to be negotiated
Holding128,454,401 shares, 13.1% of 983.6m shares (Schedule 13D/A no. 3, 30 Jun 2026); right to designate one director and one board observer (collaboration agreement, 8-K Ex 10.2 of 27 May 2025)
Supplypayments for parts and materials $1.7m in 9M 2026; embedded finance lease $7.2m (10-Q)

9 Ownership, Voting Power & Annual Meeting

  • One share class: 1.02bn shares at 2 Nov 2026, one vote each. Toyota holds 13.10%, entities of founder and CEO JoeBen Bevirt 9.40%, Baillie Gifford 6.37% and director Paul Sciarra's trust 5.76% (2026 proxy); directors and executive officers 20.35%.
  • Dilution sources: about 48.6m shares underlie the convertible notes (capped calls to $22.70), 5,833,333 Delta warrant shares at $12 subject to a milestone, about $50.0m of Resonant stock at $7.4752 (about 6.7m shares, derived) and $620.0m left under the at the market program.
  • 2026 annual meeting (2 Jun 2026): directors Paul Sciarra (98.9% for), Halimah DeLaine Prado (92.9%) and Laura Wright (98.4%) elected; PwC ratified; say on pay 98.6% for.
  • Insiders: 139 Forms 4 with sales of 5.67m shares for about $52.3m, about $46.5m under pre arranged trading plans; CEO Bevirt sold 3.85m shares for about $33.6m; open market purchases of 1,100 shares by one director.
Table 9.1 Annual meeting vote results, 2 Jun 2026
ProposalFor (m votes)Against (m votes)Abstain (m votes)For as % of votes castResult
Elect Paul Sciarra (Class II)524.75.7n/a98.9Elected
Elect Halimah DeLaine Prado (Class II)493.037.4n/a92.9Elected
Elect Laura Wright (Class II)522.08.5n/a98.4Elected
Ratify PwC for FY2026735.84.11.999.5Approved
Say on pay (advisory)521.17.41.998.6Approved
Director votes show withheld in the against column. 741,807,477 shares, about 75% of the record date total, were present. Broker non votes 211,377,432 on each item except the auditor ratification. Source: 8-K Item 5.07 of 4 Jun 2026.

Annual meeting

  • No meeting transcript or remarks were filed; the Item 5.07 8-K of 4 Jun 2026 reports only the vote results.
Table 9.2 Holders and voting power
HolderSourceSharesShare of common stock
Toyota Motor Corporation and affiliates2026 proxy; Schedule 13D/A no. 3 of 30 Jun 2026 (13.1%)128,454,40113.10%
Entities affiliated with The Joby Trust (JoeBen Bevirt)2026 proxy92,154,6579.40%
Baillie Gifford & Co2026 proxy (13G/A at 31 Dec 2025: 49,570,755, 5.4%)62,419,8036.37%
Sciarra Management Trust (director Paul Sciarra)2026 proxy56,520,9805.76%
BlackRockSchedule 13G filed 28 Jul 2026, at 30 Jun 202650,490,8555.1%
VanguardSchedule 13G/A no. 2 at 13 Mar 202600.0%
Directors and executive officers (15)2026 proxy, 31 Mar 2026199,594,83720.35%
Shares outstanding, 2 Nov 202610-Q Q3 2026 cover1,016,642,259100%
One class of common stock, one vote per share. Proxy percentages use 980,638,400 shares at 31 Mar 2026. Bevirt and Sciarra holdings include trusts; the director group includes both.
Table 9.3 Insider sales, transaction dates 21 Nov 2025 to 2 Nov 2026
InsiderShares soldValue ($m)
JoeBen Bevirt, CEO3,852,85233.56
Paul Sciarra, director750,0007.61
Rodrigo Brumana, CFO275,7332.94
Eric Allison, Chief Product Officer259,9842.51
Bonny Simi, President of Operations149,9301.86
Kate DeHoff, executive officer181,6231.86
Didier Papadopoulos, former President of Aircraft OEM95,3941.03
Gregory Bowles, Chief Policy Officer97,0370.92
All insiders, 139 Forms 45,665,51852.32
About $46.5m of the sales were under pre arranged trading plans. Director Michael Thompson bought 1,100 shares at $13.24 on 31 Dec 2025. Values are sums of reported prices times shares.

10 Risk Factors

  • Item 1A of the FY2025 10-K holds 57 risk factors against 50 a year earlier, with words up from 12,524 to 14,408: 8 added (six on Blade, one on tariffs, one on foreign ownership limits), 1 merged and 5 materially reworded. The Q1 2026 10-Q adds litigation and Middle East exposure; the Q3 2026 10-Q adds the Resonant purchase and the Aerosonic verdict.
Table 10.1 Risk factors and legal matters with filed figures
RiskDisclosure and change
Certification and launchStage 4 more than 80% complete (10-Q); letter chart shows stage 5 at 25% (Joby) and 14% (FAA) on 30 Oct 2026; TIA flight testing expected H1 2027; first passengers targeted in 2026 (10-Q).
Losses and capital needsFY2025 net loss $929.8m; accumulated deficit $3.35bn; TTM free cash flow ($784.5m); second Toyota tranche subject to conditions.
Litigation (new in 2026 Forms 10-Q)Aerosonic verdict $116.9m with an injunction motion; Archer ITC case on 4 patents could bar imports of components; final decision scheduled by 14 Sep 2027.
Resonant Sciences purchase (new, Q3 2026 10-Q)closing depends on regulatory and national security approvals; stock consideration dilutes holders.
Blade (six new factors, FY2025 10-K)integration, accidents on third party flights, access to heliports and terminals, reliance on third party operators.
International and DubaiQ1 2026 10-Q names military actions in the Middle East as a risk to Dubai operations.
Trade policy (new)tariffs on components and raw materials, incl. batteries.

How risk factors changed

  • Comparison: 10-K FY2025 filed 27 Feb 2026 acc 0001819848-26-000160 against 10-K FY2024 filed 27 Feb 2025 acc 0001819848-25-000196.
  • Blade adds a group of six factors after the Aug 2025 acquisition.
  • Factor count rose from 50 to 57 and words from 12,524 to 14,408.
  • 2026 Forms 10-Q add litigation (Archer ITC case, Aerosonic verdict), Middle East exposure in Dubai and the Resonant purchase.
Figure 10.1 Risk factors by change against the prior filing
Table 10.2 Size of the risk factor section
Measure10-K FY202410-K FY2025
Risk factors (count)5057
Words in Item 1A12,52414,408
Table 10.3 Risk factors added, removed and materially reworded
ChangeRisk factorWhat changed
AddedGlobal trade policies and tariffsNew factor on 2025 US tariffs and reciprocal tariffs, with supply chain exposure for batteries and other components.
AddedBenefits of the Blade acquisition may not be realizedIntegration risk; additional payments of up to $45m, which may be paid in shares.
AddedAccidents involving small aircraft, helicopters or charter flightsLosses and publicity from accidents on Blade flights flown by third party operators.
AddedBlade markets in early stages of growthDemand for Blade passenger offerings may not continue to grow.
AddedFacilities and infrastructure for BladeAccess to heliports, terminals and airport infrastructure for Blade services.
AddedReliance on third party operatorsBlade depends on third party operators to provide and fly aircraft.
AddedImproper operation of branded aircraftConduct of third party operators flying Blade branded aircraft.
AddedCharter and bylaws on foreign ownership of an air carrierNo more than 25% of voting stock of a US air carrier may be voted by non US citizens; bylaws allow limits on such holdings.
RemovedUAM market not established with precisionMerged into the reworded factor on market adoption and pricing.
RewordedUAM market and customer adoptionTwo FY2024 factors (market size and consumer reluctance) merged into one.
RewordedErrors or vulnerabilities in software codeRetitled from the customer facing app factor; body text unchanged.
RewordedNeed for additional capitalUpdated with the Oct 2025 offering of 35,075,000 shares at $16.85 ($575.9m net), the Toyota placement of 49,701,790 shares at $5.03 and the $300.0m ATM fully sold; COVID reference removed.
RewordedToyota Investment closing conditionsFirst $250m tranche closed in May 2025; factor now covers only the second tranche; text cut from 557 to 350 words.
RewordedNew offerings and acquisitionsAdds the L3Harris turbine hybrid collaboration, the Blade acquisition and dilution risk from acquisitions; body grew from 254 to 446 words.
Table 10.4 Risk factor updates in quarterly reports since the annual filing
FilingChange disclosed
10-Q Q1 2026 filed 6 May 2026Adds a litigation factor (injunctions on importing components could force redesign and delay certification) and restates the international factor, naming military actions in the Middle East as a risk to Dubai operations.
10-Q Q2 2026 filed 6 Aug 2026No new factors; refers to the 10-K and the Q1 2026 10-Q.
10-Q Q3 2026 filed 5 Nov 2026Adds a factor on the Resonant Sciences purchase ($500.0m, $50.0m in stock at $7.4752) and a legal factor citing the Oct 2026 jury verdict of $116.9m for Aerosonic.

11 Stock Price, Scenarios & Sensitivity

  • JOBY closed at $5.08 on 13 Nov 2026, after $5.05 on 4 Nov 2026, the day of the Q3 2026 results, released after the close. The close is 68.8% below the 52 week closing high of $16.30 (6 Jan 2026) and 10.2% above the closing low of $4.61 (14 and 19 Oct 2026); down 61.5% since the FY2025 close of $13.20.
  • Market value $5.17bn on 1.02bn shares; enterprise value $3.67bn after net cash of $1.50bn; EV/sales 24.7x TTM revenue of $148.8m. No P/E, as the company reports losses. The convertible note conversion price of about $14.19 and the Feb 2026 offering price of $11.35 sit above the close; the Resonant share price of $7.4752 also sits above it.
  • Scenario basis (the report's own model assumptions, not company guidance): Joby is valued on an exit EV/sales multiple applied to FY2029 revenue, from a FY2026 base of $137.5m, the midpoint of the $135m to $140m outlook. Net cash of $1.50bn less the $450m cash part of the Resonant price, $1.05bn, is held flat on the assumption that new equity replaces cash burn; that equity appears as a higher share count. Resonant revenue enters the paths only after closing, which is pending.
Figure 11.1 JOBY monthly closing price and three year scenarios

Critical factors and core assumptions

Table 11.1 Critical factors behind the best case
FactorCurrent valueBest case requiresEvidence in filings
FAA type certificateletter chart: stage 4 at 83% / 78%, stage 5 at 25% / 14% (30 Oct 2026); TIA flight testing from H1 2027report assumption: type certificate in 2027 and Part 135 service in US eIPP citiesQ3 2026 letter
Dubai launchsecond vertiport complete; operational flight testing with a pilot planned later in 2026; six year exclusivitypaying passengers in Dubai in 2027Q3 2026 letter; 10-K
Production with Toyota17 aircraft in production; JTAMPC formed; target four a month in 2027second $250m tranche closes and output reaches four a monthForms 8-K of 7 Jan and 30 Jun 2026
Blade revenuepassenger revenue $53.2m in Q3 2026; FY2026 outlook $135m to $140mBlade growth above 20% a year until eVTOL service starts10-Q; Q3 2026 letter
DefenseUSAF contracts nearly $37m; Resonant over $100m TTM revenue (company statement in Forms 8-K), pendingResonant closes in early 2027 and grows near 40% a yearForms 8-K of 11 Aug and 4 Nov 2026
Cash and litigation$2.20bn cash and short term investments; Aerosonic verdict $116.9m, not accruedverdict reduced on appeal; burn near $800m a year10-Q Q3 2026
  • Revenue base (the report's own model assumption): FY2026 $137.5m, the outlook midpoint. FY2029 revenue: best $1.20bn, base $700m, worst $250m. Joby gives revenue guidance for FY2026 only.
  • Best case: type certificate in 2027, service in Dubai and US eIPP cities, Resonant closes and grows; revenue CAGR 105.9%; exit 8x EV/sales; 30% more shares; implied price $8.05, +59% against the close.
  • Base case: certificate in 2028, limited eVTOL revenue by FY2029, Blade and Resonant carry most revenue, further equity raises; revenue CAGR 72.0%; exit 6x EV/sales; 50% more shares; implied price $3.44, (32%) against the close.
  • Worst case: certification slips beyond 2028, Resonant does not close, Blade only; revenue CAGR 22.1%; exit 3x EV/sales; 90% more shares; implied price $0.93, (82%) against the close.
  • Share count 1.02bn at 2 Nov 2026, before about 48.6m shares underlying the convertible notes. Operating margins are not used in the EV/sales model. Peer EV/sales TTM: Archer 211.6x, BETA 99.5x.

Scenarios, three years forward

Table 11.2 Scenario analysis, FY2026 outlook midpoint to FY2029
MeasureWorst caseBase caseBest case
Revenue CAGR, 3 years (%)22.172.0105.9
Revenue, FY2029 ($bn)0.30.71.2
Exit EV/Sales (x)3.06.08.0
Implied price ($)0.933.448.05
Change against $5.08 (%)(82)(32)59
Implied annual return (%)(43.2)(12.2)16.6
DescriptionImplied price $0.93Implied price $3.44Implied price $8.05
Valuation basis (the report's own model assumptions, not company guidance): exit EV/sales on FY2029 revenue plus net cash of $1.05bn (30 Sep 2026 net cash less the $450m cash part of the Resonant price), held flat as new equity is assumed to replace cash burn; share count 1.02bn plus 30% (best), 50% (base) or 90% (worst). Joby pays no dividend.
Figure 11.2 Three year price scenarios

Sensitivity analysis

Table 11.3 Sensitivity of implied price to revenue CAGR and exit EV/Sales
Revenue CAGR \ EV/Sales3x5x6x8x12x
20%$1.15$1.46$1.62$1.93$2.56
40%$1.43$1.92$2.17$2.66$3.65
60%$1.79$2.53$2.90$3.64$5.12
70%$2.01$2.90$3.34$4.23$6.00
90%$2.54$3.78$4.40$5.63$8.11
Cells show implied share price in year 3. Close of 13 Nov 2026 $5.08. Blue cells sit above it, red cells below. Each cell uses net cash of $1.05bn held flat and 1.52bn shares (1.02bn plus 50%, the base case assumption); revenue grows from the $137.5m FY2026 base.

Disclaimer

This analysis is for information only and is not financial advice. It is derived from public SEC filings retrieved via sec-api.io and is not a publication of the U.S. Securities and Exchange Commission. Scenario values are model outputs under stated assumptions and are not forecasts. Data as of 15 Nov 2026, with filings to 5 Nov 2026 and the share price at the 13 Nov 2026 close.

Sources

All company and peer figures are read from SEC filings retrieved through the sec-api.io MCP server.

Table A.1 Filings used, with accession numbers
FormPeriodFiledAccession number
10-QQ3 20265 Nov 20260001819848-26-000533
8-K (2.02) Ex 99.1 release, Ex 99.2 letterQ3 20264 Nov 20260001819848-26-000531
10-QQ2 20266 Aug 20260001819848-26-000435
10-QQ1 20266 May 20260001819848-26-000324
10-KFY202527 Feb 20260001819848-26-000160
10-QQ3 20256 Nov 20250001819848-25-000596
10-QQ2 20257 Aug 20250001819848-25-000499
10-QQ1 20258 May 20250001819848-25-000338
10-KFY202427 Feb 20250001819848-25-000196
10-KFY202327 Feb 20240001819848-24-000125
10-KFY20221 Mar 20230001819848-23-000059
DEF 14AFY202521 Apr 20260001819848-26-000313
Table A.2 Forms 8-K, ownership and competitor filings used
CompanyFormFiledAccession number
Joby Aviation8-K (Items 7.01, 9.01)5 Nov 20250001819848-25-000590
Joby Aviation8-K (Items 2.02, 9.01)5 Nov 20250001819848-25-000594
Joby Aviation8-K (Items 7.01, 9.01)6 Nov 20250001819848-25-000597
Joby Aviation8-K (Items 1.01, 7.01, 9.01)7 Jan 20260001819848-26-000040
Joby Aviation8-K (Items 1.01, 2.02, 2.03, 9.01)2 Feb 20260001628280-26-004597
Joby Aviation8-K (Items 2.02, 9.01)25 Feb 20260001819848-26-000154
Joby Aviation8-K (Items 4.01, 9.01)6 Mar 20260001819848-26-000165
Joby Aviation8-K (Items 1.01, 2.01, 2.03, 9.01)11 Mar 20260001819848-26-000190
Joby AviationDEF 14A 2026 proxy21 Apr 20260001819848-26-000313
Joby Aviation8-K (Items 5.02)22 Apr 20260001819848-26-000316
Joby Aviation8-K (Items 2.02, 9.01)5 May 20260001819848-26-000321
Joby Aviation8-K (Items 5.07)4 Jun 20260001819848-26-000369
Joby Aviation8-K (Items 1.01, 9.01)30 Jun 20260001819848-26-000378
Joby Aviation8-K (Items 8.01)28 Jul 20260001819848-26-000427
Joby Aviation8-K (Items 2.02, 9.01)5 Aug 20260001819848-26-000432
Joby Aviation8-K (Items 1.01, 3.02, 7.01, 8.01, 9.01)11 Aug 20260001628280-26-055505
Joby Aviation8-K (Items 5.02)9 Sep 20260001819848-26-000453
Joby Aviation8-K (Items 8.01, 9.01)11 Sep 20260001628280-26-061440
Joby Aviation8-K (Items 2.02, 9.01)4 Nov 20260001819848-26-000531
AeroVironmentAeroVironment 10-Q9 Sep 20260001104659-26-106423
Archer AviationArcher 8-K10 Aug 20260001104659-26-093056
Archer AviationArcher 10-Q Q3 20269 Nov 20260001824502-26-000089
BETA TechnologiesBETA 8-K Ex 99.1 Q3 20263 Nov 20260001628280-26-069120
BETA TechnologiesBETA 10-Q Q3 20263 Nov 20260001628280-26-069152
Baillie GiffordSchedule 13G/A9 Feb 20260001088875-26-000016
BlackRockSchedule 13G28 Jul 20260002012383-26-002463
EHangEHang 6-K Ex 99.1 Q2 202625 Aug 20260001193125-26-364154
Eve HoldingEve 10-Q Q3 20265 Nov 20260001554855-26-002302
Kratos Defense & Security SolutionsKratos 10-Q Q3 20265 Nov 20260001069258-26-000088
Surf Air MobilitySurf Air Mobility 10-Q Q3 20265 Nov 20260001193125-26-450186
Toyota Motor CorporationSchedule 13D/A no. 330 Jun 20260001193125-26-290623
Vertical AerospaceVertical 6-K Ex 99.1 H1 202613 Aug 20260001104659-26-095461
Wheels Up ExperienceWheels Up 10-Q Q3 20265 Nov 20260001628280-26-070658
Table B.1 Exhibits to Forms 8-K filed in the last twelve months
FiledExhibitDocumentContent
5 Nov 2025EX-99.1Power on testing of first conforming aircraftfirst of several FAA conforming aircraft for TIA powered on; flight testing by Joby pilots expected in 2025, FAA pilots in 2026.
5 Nov 2025EX-99.1Q3 2025 results releasecash and investments $978.1m at 30 Sep 2025; about 40,000 Blade passengers in Q3 2025.
6 Nov 2025EX-99.1Kazakhstan letter of intentup to $250m of aircraft and services to Alatau Advance Air Group; includes pre delivery payments; subject to definitive agreements.
7 Jan 2026EX-10.1 and EX-99.1Ohio facility purchase agreement and release728,000 square feet in Vandalia, Ohio for $61.5m; plan to double production to four aircraft a month in 2027.
2 Feb 2026EX-1.1 to EX-10.1Underwriting agreements, indenture, notes and capped call52,863,437 shares at $11.35; $690.0m 0.75% convertible notes due 15 Feb 2032, conversion price about $14.19.
25 Feb 2026EX-99.1 and EX-99.2Q4 2025 release and shareholder letterQ4 2025 revenue $30.8m, net loss $121.5m, Adjusted EBITDA loss $154.1m; FY2026 revenue outlook $105m to $115m; H1 2026 cash use $340m to $370m excl. about $33m Ohio building.
6 Mar 2026EX-16.1Letter from Deloitte and Toucheagrees with statements in the first three paragraphs of Item 4.01.
11 Mar 2026EX-10.1Mortgage loan agreement$30.75m interest only, ten years, fixed 6.784% (10-Q); secured on the Vandalia, Ohio property.
5 May 2026EX-99.1 and EX-99.2Q1 2026 release and shareholder lettercash and investments $2.5bn at 31 Mar 2026; first FAA conforming aircraft flew; SR3 audit completed.
30 Jun 2026EX-10.1JTAMPC stockholders agreement with ToyotaJoby 49% ($0.98m), Toyota 51% ($1.02m); Future Agreements are a condition of Toyota's second $250m tranche.
5 Aug 2026EX-99.1 and EX-99.2Q2 2026 release and shareholder letterrevenue $38.6m, Blade $36.2m; net loss $245.4m; Adjusted EBITDA loss $197.0m; FY2026 revenue outlook $115m to $125m; H2 2026 cash use $385m to $415m.
11 Aug 2026EX-1.1, EX-2.1, EX-5.1, EX-99.1ATM agreement, Resonant purchase agreement and releaseResonant Sciences for $500m base price, about $450m cash and $50m stock; $750m at the market program, commission up to 3.0%.
11 Sep 2026EX-5.1Legal opinion for earn out shares2,419,801 shares issued for the Blade EBITDA milestones.
4 Nov 2026EX-99.1 and EX-99.2Q3 2026 release and shareholder letterrevenue $55.1m; net loss $211.8m; Adjusted EBITDA loss $207.9m; FY2026 revenue outlook $135m to $140m; Q3 2026 cash use $195m.